| ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up N Colombo, C Creutzberg, F Amant, T Bosse, A González-Martín, ... Annals of Oncology 27 (1), 16-41, 2015 | 1878 | 2015 |
| Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer L Alonso-Alconada, L Muinelo-Romay, K Madissoo, A Diaz-Lopez, ... Molecular cancer 13 (1), 223, 2014 | 113 | 2014 |
| L1CAM expression in endometrial carcinomas: an ENITEC collaboration study LJM van der Putten, NCM Visser, K van de Vijver, M Santacana, ... British journal of cancer, 2016 | 108 | 2016 |
| Anti-estrogen Treatment in Endometrial Cancer: A Systematic Review WJ Van Weelden, LFAG Massuger, A Romano, H Pijnenborg Frontiers in oncology 9, 359, 2019 | 89 | 2019 |
| Preoperative risk stratification in endometrial cancer (ENDORISK) by a Bayesian network model: A development and validation study C Reijnen, E Gogou, NCM Visser, H Engerud, J Ramjith, ... PLoS medicine 17 (5), e1003111, 2020 | 52 | 2020 |
| Added Value of Estrogen Receptor, Progesterone Receptor, and L1 Cell Adhesion Molecule Expression to Histology-Based Endometrial Carcinoma Recurrence Prediction Models: An … NCM Visser, M Santacana, P Bronsert, J Bulten, M Hirschfeld, E Colas, ... International journal of gynecological cancer: official journal of the …, 2018 | 52 | 2018 |
| Patient-derived xenograft models for endometrial cancer research C Moiola, C Lopez-Gil, S Cabrera, A Garcia, T Van Nyen, D Annibali, ... International journal of molecular sciences 19 (8), 2431, 2018 | 42 | 2018 |
| L1CAM as a prognostic marker in stage I endometrial cancer: a validation study E Smogeli, B Davidson, M Cvancarova, A Holth, B Katz, B Risberg, ... BMC cancer 16 (1), 596, 2016 | 37 | 2016 |
| Potential Targets' Analysis Reveals Dual PI3K/mTOR Pathway Inhibition as a Promising Therapeutic Strategy for Uterine Leiomyosarcomas—an ENITEC Group Initiative T Cuppens, D Annibali, A Coosemans, J Trovik, N Ter Haar, E Colas, ... Clinical Cancer Research 23 (5), 1274-1285, 2017 | 35 | 2017 |
| High mRNA levels of 17β-hydroxysteroid dehydrogenase type 1 correlate with poor prognosis in endometrial cancer KMC Cornel, C Krakstad, B Delvoux, S Xanthoulea, B Jori, MY Bongers, ... Molecular and cellular endocrinology 442, 51-57, 2017 | 33 | 2017 |
| DNA ploidy in curettage specimens identifies high-risk patients and lymph node metastasis in endometrial cancer TS Njølstad, J Trovik, TS Hveem, ML Kjæreng, W Kildal, M Pradhan, ... British journal of cancer 112 (10), 1656-1664, 2015 | 32 | 2015 |
| Blocking 17β‐hydroxysteroid dehydrogenase type 1 in endometrial cancer: a potential novel endocrine therapeutic approach GFJ Konings, K Cornel, S Xanthoulea, B Delvoux, MA Skowron, ... The Journal of pathology 244 (2), 203-214, 2018 | 28 | 2018 |
| The cutoff for estrogen and progesterone receptor expression in endometrial cancer revisited: a European Network for Individualized Treatment of Endometrial Cancer … WJ van Weelden, C Reijnen, HVN Küsters-Vandevelde, J Bulten, P Bult, ... Human pathology 109, 80-91, 2021 | 25 | 2021 |
| Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer SW Vrede, WJ van Weelden, NCM Visser, J Bulten, LJM van der Putten, ... Gynecologic Oncology, 2021 | 22 | 2021 |
| Impact of body mass index and fat distribution on sex steroid levels in endometrial carcinoma: a retrospective study WJ van Weelden, KE Fasmer, IL Tangen, J IntHout, K Abbink, ... BMC cancer 19 (1), 547, 2019 | 22 | 2019 |
| Reproducibility of measurement of myometrial invasion in endometrial carcinoma LJM van der Putten, K Van de Vijver, C Bartosch, B Davidson, S Gatius, ... Virchows Archiv 470, 63-68, 2017 | 21 | 2017 |
| Blood steroids are associated with prognosis and fat distribution in endometrial cancer IL Tangen, KE Fasmer, GF Konings, A Jochems, B Delvoux, S Xanthoulea, ... Gynecologic Oncology, 2018 | 17 | 2018 |
| Poor outcome in hypoxic endometrial carcinoma is related to vascular density C Reijnen, WJ van Weelden, MSJP Arts, JP Peters, PF Rijken, ... British journal of cancer 120 (11), 1037, 2019 | 16 | 2019 |
| The Effect of Fucoidan, a Potential New, Natural, Anti-Neoplastic Agent on Uterine Sarcomas and Carcinosarcoma Cell Lines: ENITEC Collaborative Study M Bobiński, K Okła, W Bednarek, A Wawruszak, ... Archivum immunologiae et therapiae experimentalis, 1-7, 2019 | 16 | 2019 |
| The Effect of Fucoidan, a Potential New, Natural, Anti-Neoplastic Agent on Uterine Sarcomas and Carcinosarcoma Cell Lines: ENITEC Collaborative Study KO Marcin Bobinski, W Bednarek, A Wawruszak, ... Arch. Immunol. Ther. Exp, 2018 | 16* | 2018 |
Johanna MA PijnenborgRadboud University Medical Center, NijmegenVerified email at planet.nl
